Literature DB >> 15103461

Role of vasopressin in the management of septic shock.

Gökhan M Mutlu1, Phillip Factor.   

Abstract

Vasopressin is a potent vasopressor for improving organ perfusion during septic shock. The rationale for the use of vasopressin is its relative deficiency of plasma levels and hypersensitivity to its vasopressor effects during septic shock. Growing evidence suggests that low-dose (<0.04 U/min) vasopressin is safe and effective for the treatment of vasodilatory shock. Although it is being used more frequently, there are no randomized clinical trials comparing vasopressin as a first-line agent to commonly used vasopressors. However, vasopressin causes arterial smooth muscle cell contraction through a non-catecholamine receptor pathway, thus it represents an attractive adjunct to the management of septic shock, especially when catecholamines are ineffective.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103461     DOI: 10.1007/s00134-004-2283-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  169 in total

1.  On the inotropic actions of arginine vasopressin in ventricular muscle of the guinea pig heart.

Authors:  S Fujisawa; T Iijima
Journal:  Jpn J Pharmacol       Date:  1999-11

2.  Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin.

Authors:  B Perras; H Pannenborg; L Marshall; R Pietrowsky; J Born; H Lorenz Fehm
Journal:  J Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.153

3.  Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.

Authors:  C Bernadich; J C Bandi; P Melin; J Bosch
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

4.  Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Authors:  Richard Moreau; Francois Durand; Thierry Poynard; Christian Duhamel; Jean-Paul Cervoni; Philippe Ichaï; Armand Abergel; Chantal Halimi; Mathieu Pauwels; Jean-Pierre Bronowicki; Emile Giostra; Cathy Fleurot; Danielle Gurnot; Olivier Nouel; Philippe Renard; Michel Rivoal; Pierre Blanc; Dimitri Coumaros; Sylvie Ducloux; Stephane Levy; Alexandre Pariente; Jean-Marc Perarnau; Jean Roche; Myriam Scribe-Outtas; Dominique Valla; Brigitte Bernard; Didier Samuel; Joël Butel; Antoine Hadengue; Andrzej Platek; Didier Lebrec; Jean-Francois Cadranel
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

5.  Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension.

Authors:  J Möhring; K Glänzer; J A Maciel; R Düsing; H J Kramer; R Arbogast; J Koch-Weser
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

6.  Baroreceptor input regulates osmotic control of central vasopressin secretion.

Authors:  M F Callahan; M Ludwig; K P Tsai; L J Sim; M Morris
Journal:  Neuroendocrinology       Date:  1997-04       Impact factor: 4.914

7.  Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries.

Authors:  P M Vanhoutte; Z S Katusić; J T Shepherd
Journal:  J Hypertens Suppl       Date:  1984-12

8.  Depletion of neurohypophyseal content of vasopressin in septic shock.

Authors:  Tarek Sharshar; Robert Carlier; Anne Blanchard; Antoine Feydy; Françoise Gray; Michel Paillard; Jean-Claude Raphael; Philippe Gajdos; Djillaii Annane
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

9.  cAMP and extrarenal vasopressin V2 receptors in dogs.

Authors:  J F Liard
Journal:  Am J Physiol       Date:  1992-12

10.  Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients.

Authors:  A Iwai; T Sakano; M Uenishi; H Sugimoto; T Yoshioka; T Sugimoto
Journal:  Transplantation       Date:  1989-10       Impact factor: 4.939

View more
  36 in total

1.  Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.

Authors:  Martin W Dünser; Andreas J Mayr; Volker Wenzel; Walter R Hasibeder
Journal:  Intensive Care Med       Date:  2004-07-23       Impact factor: 17.440

Review 2.  Differential signaling in presynaptic neurotransmitter release.

Authors:  Wim E J M Ghijsen; A G Miriam Leenders
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 3.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

4.  Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study.

Authors:  Georgios Papadopoulos; Eleni Sintou; Stavros Siminelakis; Efstratios Koletsis; Nikolaos G Baikoussis; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2010-03-28       Impact factor: 1.637

5.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

Review 6.  [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

Authors:  K Reinhart; F Brunkhorst; H Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; M Quintel; M Ragaller; R Rossaint; F Stüber; N Weiler; T Welte; K Werdan
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

7.  Vasopressin in the pediatric cardiac intensive care unit: Myth or reality.

Authors:  Vishal K Singh; Rajesh Sharma; Amit Agrawal; Amit Varma
Journal:  Ann Pediatr Cardiol       Date:  2009-01

8.  Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients.

Authors:  Nameet Jerath; Helena Frndova; Brian W McCrindle; Rebecca Gurofsky; Tilman Humpl
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

9.  Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children.

Authors:  Dincer Yildizdas; Hacer Yapicioglu; Umit Celik; Yasar Sertdemir; Emre Alhan
Journal:  Intensive Care Med       Date:  2007-12-19       Impact factor: 17.440

10.  [Vasopressin as a rescue vasopressor agent. Treatment of selected cardiogenic shock states].

Authors:  V D Mayr; G Luckner; S Jochberger; V Wenzel; W R Hasibeder; M W Dünser
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.